Dublin, May 01, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Hospital Infection Prevention And Control Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2013 to 2024" report to their offering. The global hospital infection prevention and control market was valued at US$ 142.6 Mn in 2015, and is expected to reach US$ 245.6 Mn by 2024, expanding at a CAGR of 6.3% from 2016 to 2024. The market experts suggest that healthcare associated infections are a costly issue faced by many hospitals across the globe. Hospital acquired infections are type of infections that are observed in patients during the course of receiving treatment for unrelated conditions. According to the World Health Organization (WHO), infectious waste contributes in this way to the risk of nosocomial infections, putting the health of hospital personnel, and patients, at risk. The Centers for Disease Control and Prevention (CDC) statistically suggested that, with approximately 300,000 occurrences each year, surgical site infections (SSIs) are the second most prevalent HAI in the United States, preceded only by urinary tract infections. At a cost of approximately US$ 10 Bn annually, this high incidence of SSIs significantly impacts the U.S. healthcare system, as well as the bottom line of individual hospitals. The occurrence of nosocomial infections has been observed worldwide in both developed and resource-poor countries. Key factors assisting the growth of hospital infections prevention and control market are rising prevalence of infections, implementation of stringent guidelines associated with hospital infection prevention and control, developing healthcare infrastructure in emerging countries, and rising number of hospitals across the world. The global hospital infection prevention and control market is segmented by infection type as pneumonia, urinary tract infection, blood stream infection, surgical site infection, MRSA and others. These are the major types of hospital acquired infections that find the highest prevalence. As sourced from the CDC, ventilator associated pneumonia and surgical site infection are the most common conditions followed by GI infection, UTI, and primary blood stream infection. Global Hospital Infection Prevention and Control Market are segmented by Product type as Infection Prevention Supplies, Infection Prevention Equipment and Infection Prevention Services. Infection prevention supplies held the largest share in the overall hospital infection prevention and control market.
Key Market Movements:
- Hospital acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries. Nosocomial infection is major cause of concern for the patient and as well as the health care providers. The rising prevalence of the nosocomial infection is major driving factor for hospital infection and prevention market.
- WHO and various others regulatory bodies at regional and national level provide guidelines for hospital infection prevention and control. The significant steps taken to control infection include to identify patients at risk of nosocomial infection, maintaining the hand hygiene, practicing standard precautionary measure to reduce the transmission and applying novel strategies to reduce VAP, CR-BSI, and CAUTI.
- In Emerging economies, there is rise in R&D and increase government initiative in health care sector. There has being introduction of key corporate hospital chains, which play major role in driving the growth and the expansion of the healthcare sector. With this rise in the number of hospital increases the chances of nosocomial infection.
Scope of the Report
Based on the therapeutic application type, the global hospital infection prevention and control market is segmented as follows: Infection Prevention Supplies:
- Disinfectants
- Protective Apparel & Textiles
- Safety-Enhanced Medical Devices
- Sterilization Supplies
- Medical Waste Disposal Supplies
Infection Prevention Equipment:
- Endoscope Reprocessors
- Sterilization Equipment
- Washing/Disinfecting Equipment
- Other Infection Prevention Equipment
Infection Prevention Services:
- Endoscope Reprocessors
- Sterilization Equipment
- Washing/Disinfecting Equipment
- Other Infection Prevention Equipment
Companies Mentioned
- 3M Company
- Ansell Ltd.
- Becton, Dickinson and Company
- Belimed AG
- Bemis Company, Inc.
- B. Braun Melsungen AG
- Cantel Medical Corp.
- Cardinal Health, Inc.
- Covidien plc.
- Crosstex International, Inc.
- Danaher Corp.
- Diversey, Inc.
- Getinge Group
- Johnson & Johnson
- Halyard Health, Inc.
- MMM Group
- Matachana Group
- Medivators, Inc.
- Purdue Pharma LP
- Sealed Air Corp.
- Semperit AG Holding
- Synergy Health plc.
- Terumo Corp.
For more information about this report visit http://www.researchandmarkets.com/research/zk...l_hospital
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Hospital Management, Infectious Disease Testing
